Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase III data support lixivaptan therapy in euvolemic hyponatremia

Nov. 29, 2011

Action Pharma presents data from phase II trial of AP-214

Nov. 29, 2011

Interim data presented from the first-in-human trial of MABp1 in advanced tumors

Nov. 29, 2011

Highly selective mGlu4 receptor positive allosteric modulator discovered

Nov. 29, 2011

Preclinical results reported for LEE-011 in human liposarcoma

Nov. 28, 2011

Angiogenesis inhibitor may enhance effects of therapy with oncolytic virus

Nov. 28, 2011

Japanese researchers identify new biomarker for diagnosis/monitoring of RA

Nov. 28, 2011

Mibefradil dihydrochloride given with temozolomide in murine glioma model

Nov. 28, 2011

In vitro and clinical data presented on Vitae Pharmaceuticals' renin inhibitor

Nov. 28, 2011

Multicomponent natural medication may target multiple Alzheimer's disease pathways

Nov. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...